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Medicine and Surgery, Federico II University. PAbstract Background and aims: High-protein (HP) diets have shown benefits in cardiometabolic
markers such as insulin or triglycerides but the responsible mechanisms are not known. We
aimed to assess the effect of three energy-restricted diets with different protein contents (20%,
27%, and 35%; w80% coming from animal source) on plasma adipokine concentration and its as-
sociation with changes in cardiometabolic markers.
Methods: Seventy-six women (BMI 32.8  2.93) were randomized to one of three calorie-
reduced diets, with protein, 20%, 27%, or 35%; carbohydrates, 50%, 43%, or 35%; and fat, 30%,
for 3 months. Plasma adipokine (leptin, resistin, adiponectin, and retinol-binding protein 4;
RBP4) levels were assessed.
Results: After 3 months, leptin concentration decreased in all groups without differences among
them, while resistin levels remained unchanged. Adiponectin concentration heterogeneously
changed in all groups (P for trend Z 0.165) and resistin concentration did not significantly
change. RPB4 significantly decreased by 17.5% (31.7, 3.22) in 35%-protein diet (P for
trend Z 0.024 among diets). Triglycerides improved in women following the 35%-protein diet
regardless of weight loss; RBP4 variation significantly influenced triglyceride concentration
change by 24.9% and 25.9% when comparing 27%- and 35%- with 20%-protein diet, respectively.
Conclusions: A 35%-protein diet induced a decrease in RBP4 regardless of weight loss, which was
directly associated with triglyceride concentration improvement. These findings suggest that HP
diets improve the cardiometabolic profile, at least in part, through changes in adipokine secre-
tion. Whether this beneficial effect of HP diet is due to improvements in hepatic or adipose tissue
functionality should be elucidated.
Clinical trial registration: The clinical trial has been registered in ClinicalTrials.gov (Identifier:
NCT02160496).
ª 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the
Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery,
Federico II University. Published by Elsevier B.V. All rights reserved.eptide; BMI, Body mass index; CRP, C-reactive protein; GGT, Gamma-glutamyl transpeptidase; GPT,
1c, Glycated hemoglobin; HP, High protein; NPY, Neuropeptide Y; RBP4, Retinol-binding protein 4.
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2 R. Mateo-Gallego et al.Introduction
Obesity has become a major global health problem because
it reduces life expectancy, entails an important socio-
economic impact, and is strongly associated with a num-
ber of comorbidities including metabolic syndrome, type 2
diabetes, and cardiovascular disease [1,2]. Overweight and
obesity are associated with excess fat mass and adipocyte
dysfunction [3]. The adipose tissue plays a key role in the
regulation of energy metabolism and lipid and glucose
blood homeostasis through its ability to secrete numerous
proteins collectively known as adipokines [4,5]. The meta-
bolic abnormalities induced by excess weight are highly
associated with peripheral insulin resistance and exces-
sive release of free fatty acids from adipocytes, and both
these processes are considered markers of adipose tissue
dysfunction [4,6,7]. Altered secretion of adipokines is a
consequence of adipose tissue dysfunction and is a potent
mediator of the inflammatory state and metabolic disor-
ders associated with obesity [5e8].
Recent evidence showed that energy-restricted high-
protein (HP) diets induce remarkable weight loss and
result in a greater improvement of cardiometabolic pa-
rameters such as insulin sensitivity, plasma triglyceride, or
HDL cholesterol levels when compared with carbohydrate-
dense hypocaloric diets [9,10]. Hence, HP hypocaloric diets
have been proposed as a potential approach in the treat-
ment of type 2 diabetes [11,12]. In this line, our previous
work demonstrated that an energy-restricted diet with
35% of calories from proteins more effectively improved
the metabolic abnormalities associated with obesity in
comparison with an energy-restricted diet that is low in
protein content, independently of weight loss [10]. How-
ever, the mechanisms responsible for these differential
effects of HP diets are unknown. Low-calorie HP diets tend
to preserve fat-free mass and achieve higher fat mass
reduction, and this mechanism has been proposed as a
potential driver of their beneficial effects on lipids con-
centration or insulin resistance [13,14]. However, other
studies could not confirm this mechanism as plausible
[15]. Improvement in functionality rather than depletion
in adipose tissue is a reasonable hypothesis that has been
proposed too [4,5]. Some recently reviewed studies have
described an increase in adiponectin and a decrease in
RPB4 concentrations after weight loss, which have been
related to glucose metabolism improvement [16]. How-
ever, few studies have explored the effect of HP diets on
adipokine concentration by showing divergent effects
among different cytokines. In addition to protein quantity,
the source and quality of protein could play an essential
role in its beneficial effects on metabolism. Animal protein
consumption is associated with cardiometabolic param-
eter benefits, mainly in insulin resistance, blood pressure,
or adiposity-related metabolites, among others [17e19].
Thus, we aimed to explore the relation between weight
loss and plasma adipokine concentration associated with
different adipose tissue functions and whether energy-
restricted HP diets (80% of whom coming from lean animal
protein) could induce further improvement in adipose tissuePlease cite this article in press as: Mateo-Gallego R, et al., Different pro
profile irrespective of weight loss in overweight and obese women,
doi.org/10.1016/j.numecd.2017.10.024functionality beyondweight loss, which could be postulated
as amechanism responsible for the cardiometabolic benefits
of HP diets associated with weight loss.
Methods
Study population
The study protocol has been previously described else-
where [10]. Briefly,womenwere recruited toparticipate in a
3-month weight loss intervention study that was carried
out at a University Hospital in northern Spain. Only women
were selected to homogenize the study findings. Other in-
clusion criteria included age 18e80 years, body mass index
(BMI) 27.5e45 kg/m2, and stable weight (3 kg) in the
previous 3 months. The exclusion criteria included hypo-
thyroidism, uncontrolled type-2 diabetes (glycated hemo-
globin (HbA1c)> 8%), any other disease that could interfere
with the ability to comply with the study protocol, and
current lipid-lowering or anti-diabetic drugs. Women tak-
ing supplements of phytosterols, omega-3 fatty acids, or any
obesity drug were also excluded. Among participants
meeting the study inclusion criteria, 91 women were
randomly selected for randomization to one of three diets. A
total of 80 women completed the 3-month dietary inter-
vention period.
All subjects provided written informed consent to
participate in the study. The studyprotocolwas approvedby
the ethical committee of our institution (Comité de Ética e
Investigación Clínica de Aragón); all procedures were in
accordance with the ethical standards of that committee.
This clinical trial was registered at ClinicalTrials.gov under
identifier NCT02160496.
Study design
The study consisted of a 3-month weight loss intervention
phase, which has been previously explained in detail [10].
We selected a 3-month period of time according to previous
findings of weight loss effect on adipokine concentrations
and considering that diet-induced cardiometabolic
parameter changes stabilize in <4 weeks [16,20]. Inter-
vention included individual consultations to reinforce
messages and motivate weight loss. Clinical, anthropo-
metric, dietary, and biochemical variables were assessed at
baseline and after 3 months of dietary intervention.
The study consisted of a three-arm design, with subjects
randomly assigned to one of three energy-reduced diets:
20%, 27%, or 35% protein. The rest of macronutrients were
distributed as follows: protein, 20%, 27%, or 35%; carbohy-
drates, 50%, 43%, or 35%, respectively; and fat, 30% in all diets.
Once all screening visits were concluded, all subject data
were recorded in a data file. The first woman to be included
in the study was allocated to the 20%-protein diet, the sec-
ond to the 27%-proteindiet, the third to the35%-proteindiet,
and so on. Participants were blinded to their assigned
macronutrient composition. Low-calorie diets involved a
caloric restriction of 600 kcal per day, which was applied to
total daily energy expenditure energy intakes. They weretein composition of low-calorie diet differently impacts adipokine
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High protein intake and adipokine improvement 3estimated by multiplying the activity factor by resting en-
ergy expenditure calculated by HarriseBenedict equation.
Approximately 80% of the protein came from lean animal
sources, mainly lean lamb meat but also chicken or turkey,
low-fat dairy products, etc. More information about diet
composition and an example of a daily menu has been
previously provided [10]. All participants were provided
with physical activity advice that was in accordance with
their physical status. Patients were counseled to increase
exercise at each monitoring visit depending on the training
reported at each visit to promote weight loss. Physical ac-
tivity advice was quite heterogeneous because of varying
fitness conditions of women (i.e., walking 1 h a day or
running 30 min three times a week).
Dietary and physical activity assessments were per-
formed at baseline and after 3 months of dietary inter-
vention using a 3-day weighed food record and assessed
according to the Spanish food composition tables and a
validated questionnaire, respectively [21,22].
Body weight and composition
Anthropometric measurements (body weight and waist
circumference) were evaluated at baseline (randomiza-
tion) and after 3 months of dietary intervention. Body
composition was assessed using bioelectrical impedance
through the bipolar foot-to-foot technique (Tanita TBF
410 GS, Omron Corporation, Tokyo, Japan). Abdominal fat
deposits were also measured using bioelectrical imped-
ance (TanitaViScan AB-140, Omron Corporation) by
evaluating visceral fat. Measurements were performed in
the abdominal area with the patient in supine position
with her hands on her chest. Abdominal fat composition
was always determined at the navel, with an area 10 cm
around it clear. As established by the manufacturer,
abdominal visceral fat was expressed on a scale of 0e35.
All measurements were taken in accordance with the
recommended guidelines: no food or drink 3 h prior to
measurements, no exhausting exercise 12 h prior to
measurements, and no alcohol or caffeine consumption
24 h prior to measurements [23].
Clinical and laboratory parameters
Blood pressure was measured in triplicate with a validated
semiautomatic oscillometer (Omron M3, Omron Corpora-
tion, Hoofddorp, The Netherlands). Blood samples were
drawn by venipuncture after 12 h of fasting at the
randomization visit and at the 3-month visit. Levels of total
cholesterol, triglycerides, HDL cholesterol, gamma-
glutamyl transpeptidase (GGT), and glutamic-pyruvic
transaminase were measured using standard enzymatic
methods. LDL cholesterol levels were estimated using the
Friedewald formula when serum triglycerides were
<400mg/dL. Levels of non-HDL cholesterolwere calculated
as total cholesterol minus HDL cholesterol. We used the
homeostasis model assessment-estimated insulin resis-
tance (HOMA-IR) as a marker for insulin resistance. Blood
glucose levels were measured by the glucose-oxidasePlease cite this article in press as: Mateo-Gallego R, et al., Different pro
profile irrespective of weight loss in overweight and obese women,
doi.org/10.1016/j.numecd.2017.10.024method. Insulin levels were measured by radioimmuno-
assay. HOMA-IR was estimated as fasting serum glucose
(mg/dL)  plasma insulin (mU/mL)/405. HbA1c concentra-
tion was determined using high-performance liquid
chromatography. C-reactive protein was determined by
nephelometry using IMMAGE-Immunochemistry System
(Beckman Coulter, USA).
Adipokine determination
We determined leptin, adiponectin, resistin, and retinol-
binding protein 4 (RBP4) as relevant adipokines related to
weight loss according to previous studies [16]. Adipokine
profiles were determined using the Human Adipokine
Magnetic Bead Panel 1 (adiponectin and resistin), Human
Adipokine Magnetic Bead Panel 2 (leptin) and Human
Kidney Injury Magnetic Bead Panel 6 (RBP4) protocols
from the MILLIPLEX MAP Kits (Cat. #. HADK1MAG-61K,
HADK2MAG-61K, HKI6MAG-99K, Millipore). Analyses
were performed in duplicates, and plasma sample di-
lutions were done according to the detection range of each
panel. Briefly, adipokine assay plates were washed with
assay buffer in an orbital plate shaker for 10 min at room
temperature. The assay buffer was decanted, and the
standards, controls, and diluted plasma samples were
mixed with the assay buffer in each well. After the addi-
tion of fluorescently labeled capture antibody-coated
beads, plates were incubated overnight at 4 C on an
orbital shaker. After overnight incubation with capture
antibodies to detect adiponectin, resistin, leptin, and RBP4,
the well content was removed by washing as indicated in
the instructions provided by the manufacturer. Bio-
tinylated detection antibodies were then added to the
wells and incubated for 1 h at room temperature while
shaking. After incubation, streptavidin-phycoerythrin was
added to each well, and plates were incubated for 30 min
at room temperature with shaking. After this incubation
period, samples were washed as previously described and
resuspended in Sheath Fluid for 5 min. Plates were run on
a LABSCAN 100 (Luminex), and data were collected and
analyzed using the Luminex xPONENT software.
Statistical analyses
We selected leptin change to calculate sample size because
there are only four studies exploring HP diet effect on adi-
pokine concentration, and only one reported significant
differences in leptin change after dietary intervention [16].
Leptin variability was estimated as 78.5 ng/mL, and we ex-
pected a difference in leptin change after a dietary inter-
vention of 50 ng/mL among groups. A total sample size of 42
subjects per group was obtained by considering 90% power
(Zb unilateral Z 1.282) to detect a between-treatment
group difference and a confidence interval (1-a) of 95%
(Za unilateralZ 1.645). Continuous variables are expressed
as mean SD, mean (95% confidence interval) or median
(25th percentile-75th percentile) according to their distri-
bution. Categorical variables are reported as percentages.
ANOVA and KruskaleWallis tests were performed for thetein composition of low-calorie diet differently impacts adipokine
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applicable, post hoc adjusted comparisons were performed
with the Bonferroni correction. Categorical variables were
compared using the Pearson chi-squared test by including
inter-group comparison. Pearson’s and Spearman’s tests of
correlation were applied as appropriate. Differences in
paired clinical and biochemical variables were calculated
with the dependent t-test for paired samples or with the
Wilcoxon test. To assess differences in adipokine concen-
tration amongdiets and the effect of type of diet on different
cardiometabolic parameter changes and the effect of RBP4
in this association, we applied multiple linear regression
while including weight loss as an independent variable. All
statistical analyses were performed with SPSS version 24.0
(SPSS Inc., Chicago, IL, USA), and significance was set at
P < 0.05.Results
Baseline characteristics and weight loss after dietary
intervention
Ninety-one women were enrolled into the study, of whom
80 completed it and attended at 3-month visit. Adipokine
levels were determined in women with high dietary
intervention compliance. High compliance was defined as
protein consumption 3% of that prescribed, which was
assessed by dietary analysis; four women were excluded
(Fig. 1). Baseline clinical, biochemical, and dietary charac-
teristics of 76 women in whom adipokine concentrations
were analyzed are shown in Table 1. There were no91 selected
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Figure 1 Flowchart of random
Please cite this article in press as: Mateo-Gallego R, et al., Different pro
profile irrespective of weight loss in overweight and obese women,
doi.org/10.1016/j.numecd.2017.10.024statistically significant differences at baseline between
women assigned to each diet. Adipokine concentrations at
baseline did not differ between women randomized to the
different diets as shown in Table 2.
Metabolic changes after dietary intervention
Metabolic changes after weight loss in women in whom
adipokine levels were analyzed are shown in
Supplemental Table 1. They are quite similar to those that
we observed in all women who were included in the study
that has been previously published [10]. Systolic blood
pressure, glucose, and HOMA significantly decreased
within 27%- and 35%-protein diets after dietary interven-
tion. HDL cholesterol significantly decreased in 20%- and
35%-protein diets, and we observed an improvement in
lipid profile and GGT concentration only in the highest
protein diet group. Fat mass, fat-free mass, and visceral fat
reductions were noted in all groups. We observed statis-
tical differences between diets in total cholesterol, tri-
glycerides, and HDL cholesterol changes, noting the
highest decreases in 35%-protein diet group.
Adipokine change after dietary intervention
Weight loss after dietary intervention was 9.24  3.60%,
9.93  5.20%, and 10.7  4.28% in 20%-, 27%-, and 35%-
protein diets, respectively, without statistically significant
differences between diets (PZ 0.56). Changes in adipokine
concentrations after 3 months of dietary intervention and
according to the diet group are shown in Table 2. RBP4
concentration significantly changed by 12.5% (2.70, 27.8), for randomization visit
omen randomized to
7%-Protein diet
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Age, years 43.7  9.74 45.1  8.52 43.2  9.17 0.70
Weight, kg 86.1  8.68 88.3  9.40 85.1  8.60 0.41
BMI, kg/m2 32.5  3.07 33.7  2.68 32.2  2.97 0.16
Waist circumference, cm 99.0  7.38 100  9.30 101  12.0 0.82
Systolic blood pressure, mmHg 124  12.0 124  20.0 119  13.1 0.43
Diastolic blood pressure, mmHg 77.7  9.23 82.1  11.5 79.6  9.76 0.32
Total cholesterol, mg/dL 208  40.0 222  27.0 212  34.0 0.34
HDL cholesterol, mg/dL 54.3  11.1 55.9  9.28 58.0  11.9 0.49
Triglycerides, mg/dL 98.0 [72.0e128] 113 [82.3e154] 114 [92.0e149] 0.39
LDL cholesterol, mg/dL 127  45.5 140  22.8 129  26.6 0.35
Non-HDL cholesterol, mg/dL 154  35.3 163  23.6 154  27.5 0.41
Glucose, mg/dL 91.4  11.0 90.6  15.3 85.9  8.54 0.22
HOMA-IR 39.0 [24.5e72.2] 38.9 [30.9e82.1] 39.3 [25.1e53.1] 0.59
HbA1c, % 5.46  0.31 5.42  0.40 5.42  0.29 0.90
GGT, U/L 18.0 [13.0e27.5] 20.0 [16.0e31.0] 20.0 [14.0e30.0] 0.38
ALT, U/L 18.0 [13.0e24.0] 16.0 [12.0e25.8] 15.0 [13.0e21.0] 0.83
CRP, g/L 4.55 [1.68e7.33] 3.60 [1.50e8.20] 4.20 [1.85e8.60] 0.67
Fat mass, kg 34.2  6.61 36.0  7.06 35.6  7.23 0.65
Fat free mass, kg 46.7  5.85 48.2  4.12 46.3  2.97 0.26
Visceral fat, level 9.10  1.79 9.71  2.12 9.22  2.28 0.54
Physical activity level, METs/min 954 [371e1400] 693 [479e1328] 693 [480e1386] 0.89
Dietary intakec
Energy, kcal 1925  428 1804  438 1893  416 0.60
Protein, % 21.0 [17.3e23.2] 21.6 [17.5e23.8] 19.4 [16.9e23.0] 0.58
Animal protein, % 15.0 [12.4e19.2] 17.3 [13.3e20.4] 15.1 [11.1e18.7] 0.43
Vegetal protein, % 4.29 [3.86e5.47] 4.36 [3.62e4.89] 4.90 [3.82e5.77] 0.91
Total Fat, % 44.9  7.04 44.7  5.70 43.8  5.37 0.78
Monounsaturated fat, % 21.1  3.44 20.4  3.50 19.9  3.56 0.52
Polyunsaturated fat, % 6.18 [5.25e7.70] 5.77 [5.00e7.56] 5.96 [5.29e7.18] 0.64
Saturated fat, % 13.3 [10.8e16.2] 13.6 [12.0e16.2] 14.0 [11.3e16.0] 0.55
Carbohydrates, % 34.4 [29.0e38.7] 33.9 [27.3e37.3] 36.3 [30.1e43.9] 0.34
Sugars, g 66.1 [54.6e79.0] 64.4 [52.1e84.8] 73.7 [58.1e102] 0.96
Fiber, g 18.7  9.16 16.3  5.62 17.9  6.43 0.49
Alcohol, g 0 [0e0] 0 [0e1.68] 0 [0e0.57] 0.58
BMI denotes body mass index; HOMA-IR, homeostasis model assessment-estimated insulin resistance; HbA1c, glycated hemoglobin; GGT,
gamma-glutamyl transpeptidase; ALT, alanine aminotransferase; CRP, C-reactive protein.
a Values are mean  standard deviation (SD) or median [percentile 25epercentile 75] as applicable.
b P refers to differences calculated by ANOVA or KruskaleWallis tests, as appropriate.
c Dietary intake expressed as % of total consumed energy or grams per day.
High protein intake and adipokine improvement 53.56% (9.87,17.0), and17.5% (31.7,3.22) in 20%-, 27%-,
and 35%-protein diets, respectively (P Z 0.008). We
observed statistically significant differences when we
compared the 35%-protein diet with 20%- and 27%-protein
diets (P for trend Z 0.004). Women following the 35%-
protein diet showed 30% greater decrease in RBP4 than
those following the 20%-protein diet (PZ 0.005; PZ 0.032
after adjusting for weight loss). Leptin levels significantly
decreased by43.0% (55.3,30.7),36.8% (47.1,26.1),
and 50.3% (61.2, 39.5) in 20%-, 27%-, and 35%-protein
diets, respectively, without differences between diets. Adi-
ponectin concentrations changed from basal concentration
by 0.60% (15.8, 14.6), 8.20% (4.93, 21.3), and 12.9%
(26.2, 0.51) in 20%-, 27%-, and 35%-protein diets, respec-
tively (P for trendZ 0.165). Changes in resistin did not show
statistically significant differences during the trial.
Association between adipokine change and weight loss
Leptin reduction showed a positive and significant corre-
lation (RZ 0.59, P< 0.001) with weight loss (SupplementalPlease cite this article in press as: Mateo-Gallego R, et al., Different pro
profile irrespective of weight loss in overweight and obese women,
doi.org/10.1016/j.numecd.2017.10.024Table 2). Weight loss resulted in a 33.3% reduction in leptin
levels (B Z 3.75; 95% CI: 2.53, 4.97; P < 0.001). RBP4 levels
were slightly correlated with weight loss, although it was
not statistically significant (R Z 0.22, P Z 0.069). Adipo-
nectin and resistin levels were not significantly correlated
with weight loss.
Fat mass and visceral fat change significantly were
correlated with leptin variation (Supplemental Table 2).
We observed a significant correlation between RBP4 levels
and fat mass changes (R Z 0.34, P Z 0.003). No significant
correlations were observed between adipokine concen-
trations and fat-free mass changes.
Association between adipokines and metabolic changes
Crude correlations between adipokine concentration and
metabolic changes are shown in Supplemental Table 2.
Leptin variation was directly correlated with HOMA and
HDL cholesterol change, adiponectin variation directly
correlatedwith HDL cholesterol change, and RBP4 variation
directly correlatedwith triglycerides concentration change.tein composition of low-calorie diet differently impacts adipokine
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Table 2 Adipokine concentration changes after 3 months of intervention according to type of diet.a
20%-protein diet 27%-protein diet 35%- tein diet Overall Pb P for trend
Mean (CI) P Mean (CI) P Mea I) P
RBP4 Baseline, 103 29.0 (23.1, 34.8) e 25.3 (20.2, 30.5) e 31.4 .1, 36.8) e 0.261 e
Average change 12.5 (2.70, 27.8) e 3.56 (9.87, 17.0) e 17. 31.7, 3.22) e 0.008
Model 1: Raw Difference vs. 20% Ref. e 8.97 (29.3, 11.3) 0.381 30. 50.9, 9.14) 0.005 0.015 0.004
Difference vs. 35% 30.0 (9.14, 50.9) 0.005 21.0 (1.45, 40.6) 0.036 Ref. e
Model 2: Adjusted for
weight loss
Difference vs. 20% Ref. e 3.92 (23.7, 15.8) 0.693 22. 43.1, 1.94) 0.032 0.033 0.027
Difference vs. 35% 22.5 (1.94, 43.1) 0.032 18.6 (0.39, 37.6) 0.055 Ref. e
Leptin Baseline, 106 27.1 (21.2, 32.9) e 28.2 (23.1, 33.2) e 28.4 .3, 33.6) e 0.937 e
Average change 43.0 (55.3, 30.7) e 36.8 (47.1, 26.1) e 50. 61.2, 39.5) e 0.210
Model 1: Raw Difference vs. 20% Ref. e 6.56 (10.2, 22.5) 0.446 7.3 23.7, 9.07) 0.376 0.211 0.294
Difference vs. 35% 7.34 (9.06, 23.7) 0.376 13.6 (1.62, 28.8) 0.079 Ref. e
Model 2: Adjusted for
weight loss
Difference vs. 20% Ref. e 7.45 (6.15, 21.04) 0.278 2.8 16.8, 11,1) 0.684 <0.001 0.553
Difference vs. 35% 2.85 (11.1, 16.8) 0.684 10.3 (2.35, 23.0) 0.109 Ref. e
Adiponectin Baseline, 103 13.7 (10.5, 16.8) e 14.9 (12.2, 17.6) e 13.3 .4, 16.1) e 0.684 e
Average change 0.60 (15.8, 14.6) e 8.20 (4.93, 21.3) e 12. 26.2, 0.51) e 0.048
Model 1: Raw Difference vs. 20% Ref. e 8.79 (11.3, 28.9) 0.028 12. 32.5, 7.95) 0.230 0.087 0.165
Difference vs. 35% 12.3 (7.95, 32.5) 0.230 21.06 (2.32, 39.8) 0.385 Ref. e
Model 2: Adjusted for
weight loss
Difference vs. 20% Ref. e 8.52 (12.2, 29.2) 0.414 11. 32.8, 9.45) 0.274 0.223 0.200
Difference vs. 35% 11.7 (9.45, 32.8) 0.274 20.2 (0.95, 39.5) 0.040 Ref. e
Resistin Baseline, 103 76.4 (51.9, 101) e 58.2 (37.0, 79.4) e 69.3 .7, 90.9) e 0.521 e
Average change 2.64 (8.17, 13.5) e 5.86 (3.51, 15.2) e 4.01 .53, 13.5) e 0.161
Model 1: Raw Difference vs. 20% Ref. e 3.22 (11.1, 17.5) 0.783 1.37 3.1, 15.8) 0.850 0.902 0.889
Difference vs. 35% 1.37 (15.8, 13.1) 0.850 1.85 (11.5, 15.2) 0.655 Ref. e
Model 2: Adjusted for
weight loss
Difference vs. 20% Ref. 4.63 (9.71, 19.0) 0.521 2.57 2.1, 17.2) 0.728 0.478 0.778
Difference vs. 35% 2.57 (17.2, 12.1) 0.728 2.07 (11.3, 15.4) 0.759 Ref. e
a Values are means (95% confidence interval). Baseline adipokine values are expressed as 103, except for adiponectin, which expressed as 6.
Average change refers to % change with respect to baseline.

























































































































































































































































































































































































































































































High protein intake and adipokine improvement 7Because of the differences in RBP4 variations between diets,
we explored the potential impact of RBP4 variation on tri-
glyceride change between them (Table 3). Women
following the 35%-protein diet showed a greater decrease in
triglyceride concentration evenwhen controlled for weight
loss (B Z 32.5; 95% CI: 54.8, 10.1, P Z 0.005), RBP4
variation explained 24.9% ((17.613.2)/17.6) and 25.9%
((32.524.0)/32.5) of the effect on triglycerides change of
27%- and 35%-protein diets with respect to 20%-protein diet
(Fig. 2). We did not find a significant effect of RBP4 on other
cardiometabolic parameter changes between different
diets (Supplemental Table 3).
Discussion
This study explores for the first time the effect of different
energy-reduced HP diets, mainly coming from lean animal
protein, on adipose tissue functionality measured through
plasma adipokine concentration and its association with
changes in lipid and glucosemetabolism. In ourwork, a 35%-
protein diet energy-restricted induced greater RBP4
improvement than energy-reduced diets with lower protein
content regardless of weight loss; and this improvement are
associated with enhanced triglycerides independently of
weight loss.
The adipose tissue is composed of adipocytes and
multiple non-adipocyte cells; including immune cells,
especially macrophages that represent up to 50% of total
cells in the presence of obesity [24]. Complex interactions
among adipose tissue cells are key factors in multiple
metabolic pathways, including regulation of energy
metabolism, satiety, food behavior, and systemic inflam-
mation. Many of the endocrine and paracrine actions of
adipose tissue are the response to adipokines secretion. Up
to 600 different adipokines have been described, many of
them with unknown functions [4]. In this study, we have
analyzed four different adipokines associated with four
differential functions of adipose tissue [4,16]. Leptin has a
central role in complex feeding behavior, appetite control,
and food intake. It acts through the central nervous system
activating proopiomelanocortin neurons and inhibiting
neuropeptide Y and agouti-related peptide (AgRP) neu-
rons. Resistin has primarily a peripheral mechanism pro-
moting endothelial cell activation, smooth muscle cell
proliferation, and increasing peripheral sympathetic nerve
activity. Consequently, high levels of resistin have been
associated with high blood pressure and risk of athero-
sclerosis in obese subjects [25]. Adiponectin is mainly
produced in mature adipocytes and it is their most abun-
dantly produced protein. Although with ubiquitous ac-
tions, adiponectin stimulates fatty acid transport and
oxidation in muscle by promoting the expression of
several genes involved in mitochondrial b-oxidation and is
regulated by PPAR-a (PPAR-a - Peroxisome proliferator-
activated receptor alpha) [26]. Adiponectin increases fat
combustion and energy utilization and is inversely asso-
ciated with plasma triglyceride and positively associated
with HDL cholesterol and insulin sensitivity [27]. RBP4 is
believed to be directly involved in the pathogenesis ofPlease cite this article in press as: Mateo-Gallego R, et al., Different pro
profile irrespective of weight loss in overweight and obese women,
doi.org/10.1016/j.numecd.2017.10.024i-tein composition of low-calorie diet differently impacts adipokine
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Figure 2 % Triglyceride change differences between diets explained by
RBP4 variation. b coefficient and P value for RBP4 change effect on
triglyceride variation after adjusting for weight loss.
8 R. Mateo-Gallego et al.nsulin resistance. Transgenic overexpression of RBP4 in
normal mice impairs muscle insulin signaling, and there is
an association between RBP4 concentration and insulin
resistance in humans [28].
In our study, leptin decreased similarly in all diets and
was directly and significantly associated with weight loss,
suggesting this adipokine as a good biomarker of mass
adipose tissue. In fact, the primary source of leptin pro-
duction is the mature adipocytes, and the intracellular fat
content of adipocytes highly correlates with leptin gene
expression [16,29]. According to the absence of differences
in the leptin levels among diets, the results of the per-
formed questionnaire including appetite, satiety, and food
behavior did not differ among groups, as previously re-
ported [10]. It is well known that even a small weight loss
induced by caloric restriction has beneficial effects on
leptin concentration. Reductions <5% of total body weight
decrease circulating levels of leptin in overweight and
obese individuals although the best improvement is
observed when weight loss is over 10% [16]. A study per-
formed in 90 obesity non-diabetic outpatients showed
decreases of 3.3% and 4.4% of weight loss that were asso-
ciated to a reduction of leptin concentrations of 16.4% and
22.8% [30]. Another study observed in 48 healthy obese
subjects a leptin reduction of 56% with a weight loss of 12%
[31]. We observed similar reductions of 43.0%, 36.8%,
and 50.3% in 20%, 27%, and 35% protein diets that ach-
ieved 9.24%, 9.93%, and 10.7% weight loss, respec-
tively. Our findings are consistent with those that
positively associated the directly proportional expression
and secretion of leptin to weight and fat mass suggesting a
great biomarker of the extent of adipose tissue indepen-
dently of diet composition obtaining the weight loss [32].
Adiponectin exhibits anti-atherogenic, insulin-sensi-
tizing, and anti-inflammatory properties [4,8]. Some au-
thors have described an increase in its concentration after
weigh loss although others have not found any significant
change [16]. Only one study has shown a decrease around
6% in its concentration in patients losing 8%e9% of body
weight in a 12-week intervention study [33]. We havePlease cite this article in press as: Mateo-Gallego R, et al., Different pro
profile irrespective of weight loss in overweight and obese women,
doi.org/10.1016/j.numecd.2017.10.024observed that adiponectin heterogeneously changed after
weight loss with a reduction in 35%-protein. No correlation
with weight loss was denoted. The reason for these con-
flicting findings is not clear. It has been suggested that
duration and calorie restriction could play an essential role
in the findings, so further investigation is needed [16].
Few studies have specifically examined the effect of
calorie-reduction intervention in RBP4 concentrations in
humans. RBP4 concentration is increased and correlated
with BMI in obese subjects, and weight reduction de-
creases RBP4 concentration [34e36]. However, the asso-
ciation between RBP4 and metabolic changes in relation
with diet composition was not previously reported. We
observed a significant reduction of 17.5% only in those
women following the 35%-protein diet. In our study, the
change in RBP4 concentration did not correlate with
weight loss in any group and the RBP4 reduction was in-
dependent of the amount of weight loss. There is limited
information on the mechanisms involved in RBP4
expression and its association with adiposity and insulin
resistance in humans [37]. Clinical studies support the
hypothesis that RBP4 has a relevant role in obesity and the
development of insulin resistance. HP diets have demon-
strated to lead to cardiometabolic benefits mainly in in-
sulin resistance. Protein source seems to play an essential
role in these findings because animal protein has recently
showed greater improvements in glucose and lipid meta-
bolism and other cardiometabolic parameters [17e19]. Our
35%-protein diet was enriched with lean meat, high in
isoleucine and leucine, and therefore, RBP4 changes could
be a potential mechanism explaining the benefits of diets
with HP content. Furthermore, RBP4 is highly expressed
not only in adipose tissue but also in the liver [38]. RBP4 is
the specific transport protein for retinol in blood, and
retinol is highly stored and catabolized to retinoic acid
isomers in the liver, which act as ligands for multiple nu-
clear receptors to regulate transcription of hundreds of
genes including many associated with glucose and lipid
metabolism [39,40]. Hence, the mechanism involved in the
greater reduction of RBP4 shown in the highest protein
diet is probably related to changes in RBP4 expression by
adipose tissue or the liver. The absence of differences in
adipose tissue-origin adipokine changes between diets in
our study suggests that the liver could be the origin of the
variations in RBP4 levels observed with a 35%-protein diet.
Our study has some limitations worth mentioning. The
short intervention time could have influenced the findings
in adipokine changes, such as adiponectin, which has been
reported tobe influenced by long-termweight loss exposure
[16]. However, most interventional studies that have
explored the effects of different weight loss interventions
have got a similar time frame, so the findings are compara-
ble. Diet compliance and physical activity were assessed by
self-reported questionnaires, which is a limitation. More
objectivemethods such as urinemicroalbumin andnitrogen
concentration determination could have provided a more
accurate assessment. Our study only involveswomen, so the
findings and conclusions could not be extrapolated to other
populations, and further research would be needed totein composition of low-calorie diet differently impacts adipokine
Nutrition, Metabolism & Cardiovascular Diseases (2017), https://
High protein intake and adipokine improvement 9confirm them.Wehave assessed adipose tissue functionality
through adipokine concentration, which is well established
[3e5]. However, future studies including in vivo experi-
ments should confirm this hypothesis.
Conclusion
In conclusion, our study indicated that weight loss induced
substantial changes in adipokines, which suggests
improvement in adipose tissue functionality. However, only
the highest protein diet induced a modification in RBP4
regardless of weight loss. This was directly associated with
triglyceride concentration improvement. These findings
suggest that HP diets improve the cardiometabolic profile,
at least in part, through changes in adipokine secretion.
Whether this beneficial effect of HP diet is due to im-
provements in hepatic or adipose tissue functionality could
not be determined in our study. A high content of lean
animal protein in diet could have played an essential role,
which should be explored in future studies to fully elucidate
the mechanisms and determine the optimal diet composi-
tion to optimize the clinical benefits of weight loss.
Financial support
This study was supported in part by three grants from the
Carlos III Research Institute: CIBERCV (co-supported by the
European Regional Development Fund (ERDF), which is





The authors thank the participants for their enthusiastic
collaboration in the study and Antonio Oliván and Patricio
Pérez from Pastores (Teruel, Spain) and I.G.P. Ternasco de
Aragón (Zaragoza, Spain), respectively, for their help with
study logistics. Martín Laclaustra research activity is fun-
ded by Agencia Aragonesa para la Investigación y el
Desarrollo (ARAID).
Appendix A. Supplementary data
Supplementary data related to this article can be found at
https://doi.org/10.1016/j.numecd.2017.10.024.
References
[1] Mozaffarian D. Dietary and policy priorities for cardiovascular
disease, diabetes, and obesity: a comprehensive review. Circula-
tion 2016;133:187e225.
[2] GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH,
Reitsma MB, Sur P, Estep K, Lee A, et al. Health effects of over-
weight and obesity in 195 countries over 25 years. N Engl J Med
2017;377:13e27.Please cite this article in press as: Mateo-Gallego R, et al., Different pro
profile irrespective of weight loss in overweight and obese women,
doi.org/10.1016/j.numecd.2017.10.024[3] Blüher M. Adipose tissue dysfunction in obesity. Exp Clin Endo-
crinol Diabetes 2009;117:241e50.
[4] Blüher M, Mantzoros CS. From leptin to other adipokines in health
and disease: facts and expectations at the beginning of the 21st
century. Metabolism 2015;64:131e45.
[5] Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation
and metabolic disease. Nat Rev Immunol 2011;11:85e97.
[6] Ruscica M, Baragetti A, Catapano AL, Norata GD. Translating the
biology of adipokines in atherosclerosis and cardiovascular dis-
eases: gaps and open questions. Nutr Metab Cardiovasc Dis 2017;
27:379e95.
[7] Blüher M. Adipose tissue dysfunction contributes to obesity
related metabolic diseases. Best Pract Res Clin Endocrinol Metab
2013;27:163e77.
[8] Chakraborti CK. Role of adiponectin and some other factors linking
type 2 diabetes mellitus and obesity. World J Diabetes 2015;6:
1296e308.
[9] Wycherley TP, Moran LJ, Clifton PM, Noakes M, Brinkworth GD.
Effects of energy-restricted high-protein, low-fat compared with
standard-protein, low-fat diets: a meta-analysis of randomized
controlled trials. Am J Clin Nutr 2012;96:1281e98.
[10] Mateo-Gallego R, Marco-Benedí V, Perez-Calahorra S, Bea AM,
Baila-Rueda L, Lamiquiz-Moneo I, et al. Energy-restricted, high-
protein diets more effectively impact cardiometabolic profile in
overweight and obese women than lower-protein diets. Clin Nutr
2017;36:371e9.
[11] Pawlak R. Low-carbohydrate, high-protein diets for management
of type 2 diabetes. Am J Clin Nutr 2013;98:247e8.
[12] American Diabetes Association. Standards of medical care in dia-
betes. Diabetes Care 2017;40:S1e2.
[13] Piatti PM, Monti F, Fermo I, Baruffaldi L, Nasser R, Santambrogio G,
et al. Hypocaloric high protein diet improves glucose oxidation
and spares lean body mass: comparison to hypocaloric high-
carbohydrate diet. Metabolism 1994;43:1481e7.
[14] Leidy HJ, Carnell NS, Mattes RD, Campbell WW. Higher protein
intake preserves lean mass and satiety with weight loss in pre-
obese and obese women. Obesity (Silver Spring) 2007;15:421e9.
[15] Te Morenga L, Mann J. The role of high-protein diets in body weight
management and health. Br J Nutr 2012;108(Suppl 2):S130e8.
[16] Klempel MC, Varady KA. Reliability of leptin, but not adiponectin,
as a biomarker for diet-induced weight loss in humans. Nutr Rev
2011;69:145e54.
[17] Jennings A, MacGregor A, Pallister T, Spector T, Cassidy A. Associ-
ations between branched chain amino acid intake and biomarkers
of adiposity and cardiometabolic health independent of genetic
factors: a twin study. Int J Cardiol 2016;223:992e8.
[18] Berryman CE, Agarwal S, Lieberman HR, Fulgoni 3rd VL,
Pasiakos SM. Diets higher in animal and plant protein are associ-
ated with lower adiposity and do not impair kidney function in US
adults. Am J Clin Nutr 2016;104:743e9.
[19] Virtanen HEK, Koskinen TT, Voutilainen S, Mursu J, Tuomainen TP,
Kokko P, et al. Intake of different dietary proteins and risk of type 2
diabetes in men: the Kuopio Ischaemic Heart Disease Risk Factor
Study. Br J Nutr 2017;117:882e93.
[20] Kris-Etherton PM, Dietschy J. Design criteria for studies examining
individual fatty acid effects on cardiovascular disease risk factors:
human and animal studies. Am J Clin Nutr 1997;65(Suppl):
1590Se6S.
[21] Mataix Verdú J, Mañas Almendros M. Tabla de composición de
alimentos españoles (Spanish food composition tables). 4th ed.
Granada, Spain: Universidad de Granada; 2003.
[22] Hagströmer M, Oja P, Sjostrom M. The International Physical Ac-
tivity Questionnaire (IPAQ): a study of concurrent and construct
validity. Public Health Nutr 2006;9:755e62.
[23] Thomas EL, Collins AL, McCarthy J, Fitzpatrick J, Durighel G,
Goldstone AP, et al. Estimation of abdominal fat compartments by
bioelectrical impedance: the validity of the ViScan measurement
system in comparison with MRI. Eur J Clin Nutr 2010;64:525e33.
[24] Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin
resistance. Gastroenterology 2007;132:2169e80.
[25] Badoer E, Kosari S, Stebbing MJ. Resistin, an adipokine with non-
generalized actions on sympathetic nerve activity. Front Physiol
2015;6:321.
[26] Yoon MJ, Lee GY, Chung J-J, Ahn YH, Hong SH, Kim JB. Adiponectin
increases fatty acid oxidation in skeletal muscle cells by sequentialtein composition of low-calorie diet differently impacts adipokine
Nutrition, Metabolism & Cardiovascular Diseases (2017), https://
10 R. Mateo-Gallego et al.activation of AMP-activated protein kinase, p38 mitogen-activated
protein kinase, and peroxisome proliferatoreactivated receptor a.
Diabetes 2006;55:2562e70.
[27] Ruan H, Dong LQ. Adiponectin signaling and function in insulin
target tissues. J Mol Cell Biol 2016;8:101e9.
[28] Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM,
et al. Serum retinol binding protein 4 contributes to insulin
resistance in obesity and type 2 diabetes. Nature 2005;436:
356e62.
[29] Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al.
Leptin levels in human and rodent: measurement of plasma leptin
and ob RNA in obese and weight-reduced subjects. Nat Med 1995;
1:1155e61.
[30] de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Bellioo D,
Conde R. Effects of a low-fat versus a low-carbohydrate diet on
adipocytokines in obese adults. Horm Res 2007;67:296e300.
[31] Claessens M, van Baak MA, Monsheimer S, Saris WH. The effect of
a low-fat, high-protein or high-carbohydrate ad libitum diet on
weight loss maintenance and metabolic risk factors. Int J Obes
(Lond) 2009;33:296e304.
[32] Wadden TA, Considine RV, Foster GD, Anderson DA, Sarwer DB,
Caro JS. Short- and long-term changes in serum leptin in dieting
obese women: effects of caloric restriction and weight loss. J Clin
Endocrinol Metab 1998;83:214e8.
[33] Keogh JB, Brinkworth GD, Clifton PM. Effects of weight loss on a
low-carbohydrate diet on flow-mediated dilatation, adhesion
molecules and adiponectin. Br J Nutr 2007;98:852e9.Please cite this article in press as: Mateo-Gallego R, et al., Different pro
profile irrespective of weight loss in overweight and obese women,
doi.org/10.1016/j.numecd.2017.10.024[34] Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP,
Henry RR, et al. Retinol-binding protein 4 and insulin resistance in
lean, obese, and diabetic subjects. New Engl J Med 2006;354:
2552e63.
[35] Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M,
et al. Serum retinol-binding protein 4 is reduced after weight loss
in morbidly obese subjects. J Clin Endocrinol Metab 2007;92:
1168e71.
[36] Vitkova M, Klimcakova E, Kovacikova M, Valle C, Moro C, Polak J,
et al. Plasma levels and adipose tissue messenger ribonucleic acid
expression of retinol-binding protein 4 are reduced during calorie
restriction in obese subjects but are not related to diet-induced
changes in insulin sensitivity. J Clin Endocrinol Metab 2007;92:
2330e5.
[37] Kotnik P, Fischer-Posovszky P, Wabitsch M. RBP4: a controversial
adipokine. Eur J Endocrinol 2011;165:703e11.
[38] Tsutsumi C, Okuno M, Tannous L, Piantedosi R, Allan M,
Goodman DS, et al. Retinoids and retinoid-binding protein
expression in rat adipocytes. J Biol Chem 1992;267:1805e10.
[39] Alapatt P, Guo F, Komanetsky SM, Wang S, Cai J, Sargsyan A, et al.
Liver retinol transporter and receptor for serum retinol-binding
protein (RBP4). J Biol Chem 2013;288:1250e65.
[40] Liu G, Ding M, Chiuve SE, Rimm EB, Franks PW, Meigs JB, et al.
Plasma levels of fatty acid-binding protein 4, retinol-binding
protein 4, high-molecular-weight adiponectin, and cardiovascu-
lar mortality among men with type 2 diabetes: a 22-year pro-
spective study. Arterioscler Thromb Vasc Biol 2016;36:2259e67.tein composition of low-calorie diet differently impacts adipokine
Nutrition, Metabolism & Cardiovascular Diseases (2017), https://
